5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide has been researched along with Hypertension, Pulmonary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lefferts, PL; Lu, W; Snapper, JR; Thabes, JS | 1 |
Franco-Cereceda, A; Holm, P; Liska, J | 1 |
2 other study(ies) available for 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and Hypertension, Pulmonary
Article | Year |
---|---|
Role of endothelin in endotoxin-induced sustained pulmonary hypertension in sheep.
Topics: Animals; Antihypertensive Agents; Dansyl Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endothelin Receptor Antagonists; Endothelins; Endotoxemia; Female; Hypertension, Pulmonary; Lymph; Male; Premedication; Pulmonary Wedge Pressure; Sheep; Thromboxane B2 | 1998 |
The ETA receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo.
Topics: Animals; Antihypertensive Agents; Dansyl Compounds; Drug Synergism; Endothelin Receptor Antagonists; Endothelin-1; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Nitric Oxide Synthase; Nitroarginine; Pulmonary Artery; Swine | 1998 |